Gilberto Jaramillo-Trujillo, Juan Sebastián Frías-Ordoñez, Hernando Marulanda-Fernandez, William Otero-Regino, Jorge Armando Mejía-Tobar
{"title":"HEPATIC ENCEPHALOPATHY IN ALCOHOL-RELATED CIRRHOSIS:A SYSTEMATIC REVIEW OF CLINICAL CHARACTERISTICS, THERAPEUTIC STRATEGIES, AND PROGNOSTIC OUTCOMES.","authors":"Gilberto Jaramillo-Trujillo, Juan Sebastián Frías-Ordoñez, Hernando Marulanda-Fernandez, William Otero-Regino, Jorge Armando Mejía-Tobar","doi":"10.1590/S0004-2803.24612026-066","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612026-066","url":null,"abstract":"<p><strong>Background: </strong>Hepatic encephalopathy (HE) is a major complication of cirrhosis; however, its characterization in alcohol-related cirrhosis (ARC) remains limited because most available evidence derives from mixed-etiology cohorts.</p><p><strong>Methods: </strong>A systematic review was conducted according to PRISMA 2020 guidelines. PubMed, EMBASE, and LILACS were searched through April 2026. Randomized controlled trials and cohort studies involving adults with ARC or documented alcohol consumption reporting HE-related outcomes were included. Risk of bias was assessed using the Cochrane RoB 2.0 tool and the Newcastle-Ottawa Scale, while certainty of evidence was evaluated using the GRADE framework. Due to substantial heterogeneity, a narrative synthesis was performed.</p><p><strong>Results: </strong>Fourteen studies involving 6,185 participants were included. HE was associated with a hospital prevalence of 18.5% and a 90-day mortality of 12.1%. Observational evidence suggested that HE was associated with increased mortality (HR 3.1 at 90 days; HR 2.9 at 1 year), while active alcohol consumption was identified as a potential adverse prognostic factor (HR 2.5). For secondary prophylaxis, rifaximin was associated with reduced recurrence (HR 0.42), predominantly as add-on therapy to lactulose. Lactulose also reduced recurrence compared with placebo. In acute HE, polyethylene glycol demonstrated faster clinical improvement than lactulose, although evidence was limited.</p><p><strong>Conclusion: </strong>Available evidence suggests that HE in alcohol-related cirrhosis may represent a clinically relevant subgroup with potentially distinct prognostic characteristics. However, current evidence remains indirect, heterogeneous, and largely derived from mixed-etiology populations, precluding definitive conclusions regarding a specific alcohol-related HE phenotype. Dedicated prospective studies are needed.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26066"},"PeriodicalIF":0.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Luciana Costa Faria, Bernardo de Faria Moraes, Paulo Lisboa Bittencourt, Cristiane Alves Villela-Nogueira, Vivian Rotman, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Maria Lúcia Ferraz
{"title":"TRENDS IN HOSPITALIZATIONS, COSTS, AND IN-HOSPITAL MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A DECADE OF REAL-WORLD EVIDENCE FROM BRAZIL'S UNIFIED HEALTH SYSTEM.","authors":"Guilherme Grossi Lopes Cançado, Cláudia Alves Couto, Luciana Costa Faria, Bernardo de Faria Moraes, Paulo Lisboa Bittencourt, Cristiane Alves Villela-Nogueira, Vivian Rotman, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Maria Lúcia Ferraz","doi":"10.1590/S0004-2803.24612026-070","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612026-070","url":null,"abstract":"<p><strong>Background: </strong>Primary biliary cholangitis (PBC) is a rare autoimmune liver disease with limited epidemiological data from Latin America.</p><p><strong>Objectives: </strong>To analyzed nationwide trends in PBC-related hospitalizations and in-hospital mortality within Brazil's Unified Health System (SUS) from 2015 to 2024.</p><p><strong>Methods: </strong>National hospital admission data for ICD-10 code K74.3 were analyzed. Hospitalization rates per 100,000 inhabitants, in-hospital mortality, costs, and mean length of stay were estimated. Temporal changes were assessed using interrupted time-series segmented regression, and descriptive analyses were stratified into pre-pandemic, pandemic (COVID-19), and post-pandemic periods.</p><p><strong>Results: </strong>Between 2015 and 2024, 2,913 hospitalizations were recorded. The annual hospitalization rate ranged from 0.11 per 100,000 in 2022 to 0.19 per 100,000 in 2020, with a mean of 0.15 per 100,000 over the study period. Mean admission-level in-hospital mortality was 15.4%, ranging from 11.7%-18.5%. Mean length of stay was 7.9 days, with little variation over time. A transient increase in hospitalizations was observed in 2020 (β2 = +0.046, P=0.03), followed by a negative slope change in the post-2020 period (β2 = -0.009, P=0.04), suggesting temporary disruption related to the COVID-19 pandemic. The Southeast had the highest hospitalization burden. Inflation-adjusted expenditures totaled R$ 11.38 million (USD 2,112,227.43), with a mean cost of R$ 3,908 (USD 725.10) per admission.</p><p><strong>Conclusion: </strong>PBC-coded hospitalizations in Brazil are infrequent but associated with substantial in-hospital mortality. Strengthening outpatient management and regional equity in hepatology care remains a public health priority.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26070"},"PeriodicalIF":0.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Priscilla Sampaio, Denis Pajecki, Marco Aurelio Santo Filho, Maria Carolina Gonçalves Dias, Marco Aurelio Santo
{"title":"NUTRITIONAL OUTCOMES AFTER ONE ANASTOMOSIS GASTRIC BYPASS VERSUS ROUX-EN-Y GASTRIC BYPASS: A ONE-YEAR COMPARATIVE STUDY.","authors":"Priscilla Sampaio, Denis Pajecki, Marco Aurelio Santo Filho, Maria Carolina Gonçalves Dias, Marco Aurelio Santo","doi":"10.1590/S0004-2803.24612026-040","DOIUrl":"10.1590/S0004-2803.24612026-040","url":null,"abstract":"<p><strong>Background: </strong>Metabolic and bariatric surgery is an effective obesity treatment. One anastomosis gastric bypass (OAGB) has emerged as an alternative to Roux-en-Y gastric bypass (RYGB); however, evidence regarding its postoperative nutritional outcomes remains limited. Objective: To compare food tolerance, gastrointestinal symptoms, and nutritional status between OAGB and RYGB one year after surgery.</p><p><strong>Methods: </strong>This retrospective, observational, comparative study included 46 patients (16 OAGB and 30 RYGB). Weight loss, laboratory parameters, dietary intake, food tolerance, and gastrointestinal symptoms were evaluated one year postoperatively. Linear regression models were adjusted for relevant confounding variables, including age, sex, and baseline values when appropriate.</p><p><strong>Results: </strong>The percentage of total weight loss (29.55% vs 26.32%) and excess weight loss (63.36% vs 58.29%) were similar between RYGB and OAGB groups (P>0.05). A high prevalence of vitamin D deficiency was observed in both groups (RYGB: 82% vs. OAGB: 92%). Elevated parathyroid hormone levels were more frequent in the OAGB group (75% vs 50%), although the difference was not statistically significant. OAGB patients showed numerically lower serum iron and reduced transferrin saturation; however, none of the patients developed anemia. Mean protein intake met the recommended levels in both groups, whereas fiber intake was below the minimum recommended level. OAGB patients presented significantly lower gastrointestinal symptom scores for diarrhea, indigestion, and total score (P<0.05). Food tolerance was satisfactory and similar between groups.</p><p><strong>Conclusion: </strong>Under structured multidisciplinary follow-up, OAGB and RYGB demonstrated comparable nutritional outcomes. OAGB appears to be a nutritionally safe alternative at one year of follow-up, with the need for ongoing monitoring of iron and vitamin D status.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26040"},"PeriodicalIF":0.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Philipe Franco do Amaral Tafner, Bruna Mattos Vanetti de Albuquerque, Fernando Girardi da Silva, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo
{"title":"RELATIONSHIP BETWEEN TIMING OF SURGERY AFTER PREOPERATIVE BILIARY DRAINAGE AND OUTCOMES FOLLOWING PANCREATODUODENECTOMY.","authors":"Philipe Franco do Amaral Tafner, Bruna Mattos Vanetti de Albuquerque, Fernando Girardi da Silva, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo","doi":"10.1590/S0004-2803.24612026-050","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612026-050","url":null,"abstract":"<p><strong>Background: </strong>The role and optimal timing of surgery following preoperative biliary drainage (PBD) in patients undergoing pancreatoduodenectomy remain controversial. Early surgery may be influenced by procedure-related inflammation, whereas delayed intervention may increase infectious complications due to biliary colonization.</p><p><strong>Objective: </strong>To evaluate the impact of the interval between biliary drainage and pancreatoduodenectomy on postoperative outcomes and its association with biliary contamination.</p><p><strong>Methods: </strong>This retrospective cohort study included 239 patients undergoing pancreatoduodenectomy between 2013 and 2025. Of these, 174 (73%) underwent PBD via endoscopic retrograde cholangiopancreatography. Patients were stratified by interval between drainage and surgery: ≤2 weeks, 3-6 weeks, and >6 weeks. The primary outcome was 90-day mortality; secondary outcomes included major complications (Clavien-Dindo ≥III). Multivariable logistic regression adjusted for confounders.</p><p><strong>Results: </strong>Surgery at 3-6 weeks was associated with the lowest rates of major complications (31.7%) and 90-day mortality (9.7%), compared with ≤2 weeks (57.1%; 28.6%) and >6 weeks (40.6%; 23.2%). Surgery outside this interval increased 90-day mortality risk (OR 2.9, 95%CI 1.07-7.83). Biliary colonization rose with longer intervals, exceeding 90% after three weeks.</p><p><strong>Conclusion: </strong>A 3-6 week interval between biliary drainage and pancreatoduodenectomy is associated with improved outcomes, suggesting an optimal window balancing inflammation and bacterial colonization.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26050"},"PeriodicalIF":0.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gustavo Carreira Xavier, Lucas Araújo Vaz, Marina Cota Caldeira, Hacer Tekin, Tarak Dhaouadi
{"title":"MLH1 AND MSH2 PROTEIN EXPRESSION LOSS AND MICROSATELLITE INSTABILITY IN COLORECTAL ADENOMAS OF PATIENTS WITH LYNCH SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS.","authors":"Gustavo Carreira Xavier, Lucas Araújo Vaz, Marina Cota Caldeira, Hacer Tekin, Tarak Dhaouadi","doi":"10.1590/S0004-2803.24612026-081","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612026-081","url":null,"abstract":"<p><strong>Background: </strong>Lynch Syndrome (LS) is a genetic condition associated with a high risk of colorectal cancer, often linked to microsatellite instability (MSI), which is caused by defects in DNA mismatch repair (MMR) genes such as MLH1 and MSH2. Although MMR deficiency and MSI are well-documented in the literature, the role of these genes in adenomas remains unclear.</p><p><strong>Objectives: </strong>To evaluate, through meta-analysis, the correlation between loss of expression of the MLH1 and MSH2 genes and MSI in adenomas from patients with LS.</p><p><strong>Methods: </strong>A systematic search was conducted in the MEDLINE, SCOPUS, and Web of Science databases up to 06/09/2025, using a strategy with descriptors related to MSI, LS, and precursor lesions. Data were analyzed using the Inverse Variance method, with 95% confidence intervals. Heterogeneity was assessed using the I-squared ( I²) statistic. Outliers were identified through statistical influence diagnostics applied to each study. Publication bias was assessed using funnel plots and Egger's regression test. Statistical analyses were performed using RStudio, version 4.4.0.</p><p><strong>Results: </strong>5 studies were included, totaling 145 adenomas from individuals with LS. A highly significant correlation was found between MSI and MSH2 expression loss (OR=13,91 [3,97-48,72]; P=0,000038; I²=0%). No significant correlation was found between MSI and loss of MLH1 expression (OR=2,19 [0,93-5,16]; P=0,073; I²=0%). Funnel plot analysis and Egger's regression test showed no significant evidence of publication bias for MLH1 (t=0.25, df=3, P-value=0.8155) or MSH2 (t=-0.79, df=3, P-value=0.4860).</p><p><strong>Conclusion: </strong>This meta-analysis found a strong, significant and consistent correlation between MSI and MSH2 expression loss in adenomas, but a non-significant association for MLH1 expression loss. The lack of statistical significance in Egger's test for both genes should be interpreted with caution due to the small number of included studies (k=5). The limited literature available highlights the need for further, larger-scale research.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26081"},"PeriodicalIF":0.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rutiane Ullmann Thoen, Larisse Longo, Bruno de Souza Basso, Pabulo Henrique Rampelotto, Anne Orgler Sordi, Félix Henrique Paim Kessler, Lisia Von Diemen, Mário Reis Álvares-DA-Silva
{"title":"DYSBIOSIS OF GUT MICROBIOTA IN PATIENTS HOSPITALIZED FOR THE TREATMENT OF ALCOHOL USE DISORDER.","authors":"Rutiane Ullmann Thoen, Larisse Longo, Bruno de Souza Basso, Pabulo Henrique Rampelotto, Anne Orgler Sordi, Félix Henrique Paim Kessler, Lisia Von Diemen, Mário Reis Álvares-DA-Silva","doi":"10.1590/S0004-2803.24612025-144","DOIUrl":"10.1590/S0004-2803.24612025-144","url":null,"abstract":"<p><strong>Background and objectives: </strong>Alcohol Use Disorder (AUD) is a global issue with a significant financial impact on health. The main objective of this study was to assess the chronic effect of alcohol on the composition and diversity of intestinal microbiota in AUD patients.</p><p><strong>Methods: </strong>Prospective cohort study in patients hospitalized for AUD treatment. Demographic, clinical, and laboratory data and inflammatory markers were assessed at the time of hospital admission for AUD-T1-group and in the control group, as well evaluation of the gut microbiota composition, while the AUD-T2-group was assessed at the discharge from hospital treatment.</p><p><strong>Results: </strong>50 participants were included in the control group and 47 admitted for AUD treatment. The mean age in the AUD-T1-group was 49.3 years, all male. Mieloperoxidase concentration was significantly higher in AUD-T1-group compared to control (P<0.001). The opposite was observed for E-selectin (P<0.001). Global alpha diversity was different among the control, AUD-T1 and AUD-T2 groups, ACE index (P<0.004), Shannon index (P<0.017), observed taxa (P=0.002). The LEfSe algorithm identified a higher abundance of Faecalibacterium, Bacteroides, Agathobacter, and Ruminococcaceae unclassified in control compared to the AUD-T1. There were no differences in the abundance of bacterial genera between the AUD-T1 and AUD-T2 groups.</p><p><strong>Conclusion: </strong>Patients with AUD exhibit changes in intestinal microbiota composition, potentially associated with low-grade inflammation and functional alterations that contribute to the development of diseases. The composition of intestinal microbiota and its bioactive metabolites may serve as novel therapeutic targets for the treatment of AUD.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e25144"},"PeriodicalIF":0.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Martin Guidi, Julio DE Maria, Virginia Machado, Gisele Salome Lopez
{"title":"INNOVATIVE RECANALIZATION TECHNIQUE USING DIATHERMIC PUNCTURE UNDER COLANGIOSCOPY FOR COMPLETE BILIARY STRICTURE.","authors":"Martin Guidi, Julio DE Maria, Virginia Machado, Gisele Salome Lopez","doi":"10.1590/S0004-2803.24612025-135","DOIUrl":"10.1590/S0004-2803.24612025-135","url":null,"abstract":"","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e25135"},"PeriodicalIF":0.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Didia Bismara Cury, Liana Cristina Bismara Cury, Ana Camila Micheletti
{"title":"REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024).","authors":"Didia Bismara Cury, Liana Cristina Bismara Cury, Ana Camila Micheletti","doi":"10.1590/S0004-2803.24612026-009","DOIUrl":"10.1590/S0004-2803.24612026-009","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (Crohn's and Ulcerative colitis) have been increasing alarmingly in Brazil. They affect mainly young people at reproductive age, which is extremely worrying in such a young country. To date, there´s no study that demonstrates how these diseases can affect pregnant women, like drug side effects and how off-springs of Brazilian patients evolve over time.</p><p><strong>Objectives: </strong>The study aimed to analyze the side effects of medications used by patients with Inflammatory Bowel Disease (IBD) during pregnancy; to assess the impact of disease activity on the course of pregnancy and fetal development and to monitor the development of these children.</p><p><strong>Methods: </strong>This was a longitudinal retrospective analysis of patients registered over time (2007/2024), regarding the medications used during the conception, side effects, complications during pregnancy and post-delivery. All patients were recruited at the Inflammatory Bowel Disease service at Scope Clinic, located in the Midwest region of Brazil.</p><p><strong>Results: </strong>Out of the 329 patients, 25 got pregnant (mean age 30.38 years), 48% were in endoscopic activity and 52% were in remission at conception time, and all patients maintained prescribed medication (chimeric and fully human anti-TNF agents, as well as immunosuppressive medications). Disease activity had direct influence on the babies' weight and on the Apgar score when compared to women in remission, but despite this fact, prematurity was not observed. No undesirable drug effects were observed in both groups (mother and fetus), endorsing their safety over this population. In the postpartum follow-up over a period of two years, no abnormalities were observed.</p><p><strong>Conclusion: </strong>This study shows the importance of continuously monitoring patients with inflammatory disease and guiding them on drug maintenance and the most appropriate time for conception.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26009"},"PeriodicalIF":0.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniella Ribeiro Einstoss Korman, Jordana de Castro Honorato, Júlia Brunetti Teles de Melo, Lucas Leonardo Knupp Dos Santos
{"title":"CHARACTERIZATION OF PATIENTS TREATED AT A UNIVERSITY OUTPATIENT CLINIC WITH FUNCTIONAL DYSPEPSIA AND ITS CORRELATION WITH MENTAL DISORDERS.","authors":"Daniella Ribeiro Einstoss Korman, Jordana de Castro Honorato, Júlia Brunetti Teles de Melo, Lucas Leonardo Knupp Dos Santos","doi":"10.1590/S0004-2803.24612026-025","DOIUrl":"10.1590/S0004-2803.24612026-025","url":null,"abstract":"<p><strong>Background: </strong>Functional dyspepsia is a common gastrointestinal disorder in clinical practice, characterized by chronic dyspeptic symptoms in the absence of identifiable organic disease, and is currently classified as a disorder of gut-brain interaction. Evidence suggests a significant association between functional dyspepsia and mental disorders, particularly anxiety and depression; however, this relationship remains insufficiently explored in national studies.</p><p><strong>Objective: </strong>To characterize the sociodemographic and clinical profile of patients treated at a university outpatient gastrointestinal care clinic with functional dyspepsia and to analyze its correlation with mental disorders.</p><p><strong>Methods: </strong>This was a cross-sectional observational study based on the analysis of medical records of patients diagnosed with functional dyspepsia according to the Rome IV criteria, treated at a university outpatient clinic in the southeast of Brazil. Sociodemographic data, lifestyle habits, clinical comorbidities, presence of concomitant mental disorders, and information on clinical evolution were collected. Statistical analyses were performed to evaluate associations between functional dyspepsia, mental disorders and clinical variables.</p><p><strong>Results: </strong>The sample consisted of 135 patients, predominantly women, with a higher prevalence of patients over 60 years of age. Most individuals were sedentary, non-smokers, and non-alcohol users, with systemic arterial hypertension being the most frequent clinical comorbidity. Mental disorders were present in nearly half of the patients, with generalized anxiety disorder and major depressive disorder being the most prevalent diagnoses, either isolated or in combination. No statistically significant associations were observed between mental disorders and most sociodemographic or clinical variables, except for obesity. During outpatient follow-up, a substantial proportion of patients with functional dyspepsia and concomitant mental disorders showed partial or complete improvement of dyspeptic symptoms.</p><p><strong>Conclusion: </strong>The findings demonstrate a high frequency of mental disorders among patients with functional dyspepsia treated at a university outpatient clinic, reinforcing the multifactorial nature of this condition. The observed association and the clinical improvement identified in a subset of patients undergoing multidisciplinary follow-up highlight the importance of integrating gastroenterology and mental health care in the management of functional dyspepsia, contributing to a more comprehensive and interdisciplinary care of the patient.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e26025"},"PeriodicalIF":0.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mariana Martins Sanches Ferreira, Philipe Franco do Amaral Tafner, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo
{"title":"PANCREATIC NEUROENDOCRINE TUMORS: CLINICOPATHOLOGICAL ANALYSIS AND POSTOPERATIVE SURVIVAL FOLLOWING SURGICAL RESECTION-A DECADE OF EXPERIENCE AT A TERTIARY UNIVERSITY HOSPITAL.","authors":"Mariana Martins Sanches Ferreira, Philipe Franco do Amaral Tafner, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo","doi":"10.1590/S0004-2803.24612025-089","DOIUrl":"10.1590/S0004-2803.24612025-089","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic neuroendocrine tumors (PNETs) are rare neoplasms of the digestive system, with variable prognoses and biological behaviors. Surgical resection remains the mainstay of treatment. Objective: To evaluate the clinicopathological characteristics and surgical outcomes of patients with PNETs who underwent resection at the Hospital de Clínicas, UNICAMP.</p><p><strong>Methods: </strong>This is a retrospective cohort study including 24 patients who underwent surgical resection between 2013 and 2023. Clinical, demographic, histopathological, and survival data were analyzed. The primary outcome was overall survival.</p><p><strong>Results: </strong>The mean age was 53.9 ± 14.4 years, with a predominance of female patients (66.7%). Most tumors were nonfunctioning (79.1%), with abdominal pain (79.2%) and weight loss (50%) being the most common symptoms. The surgical procedures performed were distal pancreatectomy (54.2%), pancreaticoduodenectomy (41.6%), and enucleation (4.2%). Histological classification revealed 62.5% grade 2 tumors, 33.3% grade 1, and 4.2% MiNEN. Mean overall survival was 70.4 ± 58 months. There was a trend toward longer survival in grade 1 tumors (98 ± 68.1 months) compared to grade 2 (59.1 ± 49.5 months; P=0.06). Postoperative mortality was 8.3%, associated with pancreaticoduodenectomy.</p><p><strong>Conclusion: </strong>Histological grading remains a key prognostic factor in PNETs. Surgical resection remains the cornerstone of treatment. Multicenter studies are necessary to validate these findings on a larger scale.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"63 ","pages":"e25089"},"PeriodicalIF":0.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149300697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}